XYMOGEN competitors

Matthew E. Monaghan is an independent director who joined the Board in October 2016, and is a member of the Audit Committee and Nominating and Corporate Governance Committee. Mr. Monaghan currently serves as President and Chief Executive Officer at Invacare Corporation (NYSE:IVC) (“Invacare”), a medical device manufacturer for the home and long-term healthcare markets, a position he has held since April 2015. Mr. Monaghan was named Chairman of the Invacare Board in May 2015. He previously served as Senior Vice President, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. (formerly known as Zimmer Holdings, Inc.) (“Zimmer”), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products from 2014 to 2015. Mr. Monaghan also has served as Operating Executive for Texas Pacific Group from 2006 to 2009 and at Cerberus Capital Management from 2003 to 2005. He started his career with 13 years in the aerospace, medical and other industrial businesses of General Electric. Mr. Monaghan is a trustee of Cleveland Clinic Avon Lake Hospital. Mr. Monaghan was a member of the board of directors of CD Diagnostics, Inc. from 2012 to 2016 and served as the chairman of the Audit Committee from 2012 to 2015 and as chairman of the board from 2015 to 2016. He holds a Bachelor’s degree in Mechanical Engineering from Cornell University, a Master’s degree in Mechanical Engineering from MIT and an MBA from INSEAD Business School in France.

John Adent is a Board Member at NEOGEN CORP and President/CEO at NEOGEN CORP and is based in Lansing, Michigan. He has worked as Chief Executive Officer at ANIMAL HEALTH HOLDINGS, INC. and Pres & CEO:Animal Health at PATTERSON COMPANIES, INC.. John studied at DEPAUW UNIVERSITY between 1986 and 1990.

Liam became President and CEO on January 1, 2018. He joined Teleflex in April 2009 and shortly thereafter assumed responsibility as President of EMEA. He was then promoted to the position of Executive Vice President and President, International in June 2012. In April 2014, Liam was appointed Executive Vice President and President, Americas. In April 2015, he was named Executive Vice President and Chief Operating Officer. From May 2016 to December 2017, he served as President and Chief Operating Officer. Prior to joining Teleflex, Liam worked at Hill-Rom where he held senior leadership positions from 2002 to 2009. He was the Vice President of International Marketing and Product Development and previously had been Managing Director of their UK & Ireland businesses. Liam holds a Bachelor of Business Studies from the University of Limerick.

Brent Eck is a Member of the Board of Directors at Kindex Pharmaceuticals. He currently serves as President and Chief Executive Officer at Metagenics.